A new analysis of U.S. safety reports has found that energy drinks and stimulant supplements are tied to disproportionately frequent reports of serious heart problems — including roughly 11 times as many reports of cardiac arrest and about 4.5 times as many reports of heart attack as would be expected for comparable products. The findings, reported by the American Heart Association and covered widely by outlets including USA Today, MSN, Medical News Today and Science Daily, have thrust a fast-growing consumer category back into the regulatory spotlight.

The headline number is striking, but the study's authors and independent experts are urging caution: the research is based on a voluntary reporting database, cannot establish that the drinks caused the events, and almost certainly undercounts the true number of cases.

What the Study Found

Researchers examined adverse-event reports submitted to the U.S. Food and Drug Administration and compared the frequency of cardiovascular complaints linked to energy drinks and stimulant-containing dietary supplements against reports involving other products in the same database. The pattern that emerged was consistent across categories: products marketed for their stimulant effects were associated with a substantially higher share of severe cardiac outcomes.

  • Cardiac arrest: approximately 11 times more reports than expected relative to other products.
  • Heart attack: approximately 4.5 times more reports.
  • Age skew: adults aged 18 to 34 accounted for nearly half of all cardiovascular reports involving these products — a group that is, in theory, at low baseline risk for cardiac events.

That last detail is what has alarmed clinicians. Older adults with known heart disease experiencing arrhythmias after a stimulant-heavy drink would be less surprising. A concentration of reports among people in their teens, twenties and early thirties points to a potentially preventable exposure in a population that assumes these beverages are benign.

How the Research Was Done — and Its Limits

The study draws on the FDA's adverse event reporting system, a passive surveillance tool that relies on consumers, clinicians and manufacturers to file reports voluntarily. That design is powerful for spotting signals — it is how regulators first flagged problems with certain painkillers and supplements — but it is also vulnerable to bias and incompleteness.

The findings “raise concerns” about cardiovascular risk from stimulant products, the authors wrote, while cautioning that adverse-event reports cannot prove causation and are subject to significant underreporting.

Because reporting is voluntary, the true incidence of cardiac events linked to energy drinks may be far higher than what the database shows. Conversely, media attention or litigation can inflate reporting for a specific product. Without controlled clinical data, researchers cannot say whether the drinks triggered the events, whether they worsened an underlying condition, or whether the people who suffered them shared other risk factors such as dehydration, extreme exercise, alcohol use or undiagnosed heart conditions.

Why Outlets Framed It Differently

Coverage of the study split along a familiar fault line. Consumer-facing outlets leaned into the arresting statistics: “Energy drinks linked to 11 times more cardiac arrest reports,” read one widely syndicated headline, while others emphasized “heart attacks and cardiac arrest in young adults.” Medical and trade publications — Medical News Today, Medical Xpress, Science Daily — foregrounded the caveats, framing the story around the question “should young adults be concerned?” and stressing that causation remains unproven.

Aggregators amplified the most dramatic framing. Newser summarized it as “Energy Drinks Linked to Cardiac Risk in Young Adults,” while regional outlets in Florida, Wyoming and elsewhere ran variations on “serious heart issues.” The consistency of the core numbers across dozens of syndicated versions underscores how a single peer-reviewed data point can travel further than its nuances.

The Bigger Picture

Energy drinks are a multibillion-dollar global industry, with products marketed heavily to adolescents and young adults through gaming, esports and extreme-sports sponsorships. A single 16-ounce can may contain 150 to 300 milligrams of caffeine — comparable to two or three cups of coffee — plus taurine, guarana, B-vitamins and, increasingly, high-dose “nootropic” stimulants. Pre-workout powders and concentrated stimulant capsules can deliver considerably more.

Regulators have moved slowly. The FDA has long said it monitors caffeine-containing products but has not imposed caffeine limits on energy drinks, and supplement stimulants often reach shelves without pre-market safety review. The American Heart Association has previously warned that energy drinks may raise blood pressure and disturb heart rhythm, particularly in young people and those with existing cardiovascular conditions.

What It Means for Consumers

For now, the study is best read as a signal rather than a verdict — one that strengthens the case for better surveillance, clearer labeling and targeted research. Cardiologists generally advise that people with known heart conditions, pregnant individuals and children avoid high-dose stimulant products, and that anyone experiencing palpitations, chest pain, fainting or shortness of breath after consuming one seek medical attention promptly.

The practical takeaway, experts say, is not that a single can will stop a young heart — but that a product class marketed as harmless fuel for late-night study sessions and workouts is accumulating enough safety reports to warrant the kind of scrutiny usually reserved for drugs.